After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.
Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results